Pathophysiology of vascular remodeling in hypertension
NF Renna, N De Las Heras… - International journal of …, 2013 - Wiley Online Library
Vascular remodeling refers to alterations in the structure of resistance vessels contributing to
elevated systemic vascular resistance in hypertension. We start with some historical aspects …
elevated systemic vascular resistance in hypertension. We start with some historical aspects …
Role of TNFα in pulmonary pathophysiology
S Mukhopadhyay, JR Hoidal, TK Mukherjee - Respiratory research, 2006 - Springer
Tumor necrosis factor alpha (TNFα) is the most widely studied pleiotropic cytokine of the
TNF superfamily. In pathophysiological conditions, generation of TNFα at high levels leads …
TNF superfamily. In pathophysiological conditions, generation of TNFα at high levels leads …
The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
JA Winkles - Nature reviews Drug discovery, 2008 - nature.com
TWEAK is a multifunctional cytokine that controls many cellular activities including
proliferation, migration, differentiation, apoptosis, angiogenesis and inflammation. TWEAK …
proliferation, migration, differentiation, apoptosis, angiogenesis and inflammation. TWEAK …
Primary graft dysfunction after heart transplantation: a thorn amongst the roses
SSA Singh, JR Dalzell, C Berry, N Al-Attar - Heart Failure Reviews, 2019 - Springer
Primary graft dysfunction (PGD) remains the leading cause of early mortality post-heart
transplantation. Despite improvements in mechanical circulatory support and critical care …
transplantation. Despite improvements in mechanical circulatory support and critical care …
Interleukins in atherosclerosis: molecular pathways and therapeutic potential
JH Von der Thüsen, J Kuiper, TJC Van Berkel… - Pharmacological …, 2003 - ASPET
Interleukins are considered to be key players in the chronic vascular inflammatory response
that is typical of atherosclerosis. Thus, the expression of proinflammatory interleukins and …
that is typical of atherosclerosis. Thus, the expression of proinflammatory interleukins and …
[HTML][HTML] Recent advances in the development of theranostic nanoparticles for cardiovascular diseases
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …
Cell death and diabetic cardiomyopathy
L Cai, YJ Kang - Cardiovascular toxicology, 2003 - Springer
Myocardial cell death is a key element in the pathogenesis and progression of various
etiological cardiomyopathies such as ischemia-reperfusion, toxic exposure, and various …
etiological cardiomyopathies such as ischemia-reperfusion, toxic exposure, and various …
Early protective role of inflammation in cardiac remodeling and heart failure: focus on TNFα and resident macrophages
S Besse, S Nadaud, E Balse, C Pavoine - Cells, 2022 - mdpi.com
Cardiac hypertrophy, initiated by a variety of physiological or pathological stimuli
(hemodynamic or hormonal stimulation or infarction), is a critical early adaptive …
(hemodynamic or hormonal stimulation or infarction), is a critical early adaptive …
Identification of a novel role for sphingolipid signaling in TNF α and ischemic preconditioning mediated cardioprotection
S Lecour, RM Smith, B Woodward, LH Opie… - Journal of molecular and …, 2002 - Elsevier
TNF α administration mimics ischemic preconditioning and neutralizing antibodies to TNFα
and IL-1 β abolish exercise-induced preconditioning. However, the pharmacology of TNFα's …
and IL-1 β abolish exercise-induced preconditioning. However, the pharmacology of TNFα's …
Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction
In this study, we used deoxyribozyme (DNAzyme) functionalized gold nanoparticles (AuNPs)
to catalytically silence tumor necrosis factor-α (TNF-α) in vivo as a potential therapeutic for …
to catalytically silence tumor necrosis factor-α (TNF-α) in vivo as a potential therapeutic for …